JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.72B |
| 2 |
Amazon
AMZN
|
+$2.99B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.6B |
| 4 |
Mastercard
MA
|
+$1.47B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.62B |
| 2 |
Apple
AAPL
|
+$3.37B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.93B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.93B |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.1% |
| 2 | Technology | 18.95% |
| 3 | Healthcare | 10.56% |
| 4 | Financials | 9.04% |
| 5 | Consumer Discretionary | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Shopify
SHOP
$216B
| $1.59B | 0.18% |
29,184,000
+5,928,699
| +25% | +$359M |
2015 Q2
33 quarters
|
|
127
Medtronic
MDT
$114B
| $1.56B | 0.17% |
19,862,452
+213,271
| +1% | +$17.9M |
2013 Q2
41 quarters
|
|
128
Yum! Brands
YUM
$39.2B
| $1.54B | 0.17% |
12,299,627
+2,249,213
| +22% | +$296M |
2013 Q2
41 quarters
|
|
129
Cigna
CI
$75B
| $1.48B | 0.16% |
5,166,161
+256,229
| +5% | +$73.1M |
2013 Q2
41 quarters
|
|
130
iShares US Treasury Bond ETF
GOVT
$41.4B
| $1.46B | 0.16% |
66,261,127
-30,665,728
| -32% | -$690M |
2015 Q4
31 quarters
|
|
131
Xcel Energy
XEL
$45.7B
| $1.46B | 0.16% |
25,442,049
-4,981,449
| -16% | -$299M |
2013 Q2
41 quarters
|
|
132
Baker Hughes
BKR
$56.2B
| $1.43B | 0.16% |
40,614,975
-12,024,425
| -23% | -$426M |
2017 Q3
24 quarters
|
|
133
iShares MSCI EAFE ETF
EFA
$76.2B
| $1.43B | 0.16% |
20,688,891
-4,839,046
| -19% | -$347M |
2013 Q2
41 quarters
|
|
134
CALL
Tesla
TSLA
$1.52T
| $1.41B | 0.16% |
5,646,500
-201,100
| -3% | -$51.7M |
2014 Q3
36 quarters
|
|
|
PXD
135
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.41B | 0.16% |
6,154,630
+448,214
| +8% | +$102M |
2013 Q2
41 quarters
|
|
136
General Dynamics
GD
$89.2B
| $1.41B | 0.16% |
6,381,583
-1,215,936
| -16% | -$269M |
2013 Q2
41 quarters
|
|
137
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
$2.03B
| $1.4B | 0.15% |
18,600,423
-1,843,373
| -9% | -$146M |
2020 Q3
12 quarters
|
|
138
Infosys
INFY
$43.8B
| $1.4B | 0.15% |
81,636,365
-1,463,133
| -2% | -$25M |
2013 Q2
41 quarters
|
|
139
Pfizer
PFE
$160B
| $1.38B | 0.15% |
41,464,283
-1,512,254
| -4% | -$53.5M |
2013 Q2
41 quarters
|
|
140
PNC Financial Services
PNC
$87.1B
| $1.37B | 0.15% |
11,156,996
+547,695
| +5% | +$68.9M |
2013 Q2
41 quarters
|
|
141
Amgen
AMGN
$222B
| $1.35B | 0.15% |
5,031,749
-73,857
| -1% | -$18.4M |
2013 Q2
41 quarters
|
|
142
HubSpot
HUBS
$11.7B
| $1.34B | 0.15% |
2,716,774
+170,381
| +7% | +$89M |
2014 Q4
35 quarters
|
|
143
ASML
ASML
$691B
| $1.33B | 0.15% |
2,264,904
+109,249
| +5% | +$72.6M |
2013 Q2
41 quarters
|
|
144
iShares Russell 1000 Value ETF
IWD
$82.4B
| $1.3B | 0.14% |
8,588,961
-221,421
| -3% | -$35.1M |
2013 Q2
41 quarters
|
|
145
Vanguard Short-Term Bond ETF
BSV
$46B
| $1.28B | 0.14% |
17,078,527
-116,652
| -0.7% | -$8.79M |
2013 Q2
41 quarters
|
|
146
Amphenol
APH
$213B
| $1.28B | 0.14% |
61,119,644
+2,613,416
| +4% | +$56.2M |
2013 Q2
41 quarters
|
|
147
Biogen
BIIB
$32.7B
| $1.28B | 0.14% |
4,985,752
+514,565
| +12% | +$138M |
2013 Q2
41 quarters
|
|
148
Charter Communications
CHTR
$12.2B
| $1.28B | 0.14% |
2,908,127
-300,768
| -9% | -$125M |
2013 Q2
41 quarters
|
|
149
Starbucks
SBUX
$105B
| $1.28B | 0.14% |
13,997,784
-148,915
| -1% | -$14.6M |
2013 Q2
41 quarters
|
|
150
iShares Russell 2000 ETF
IWM
$77.3B
| $1.28B | 0.14% |
7,220,136
-908,536
| -11% | -$171M |
2013 Q2
41 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2023 Portfolio in Review
As of Q3 2023, JP Morgan Chase held 7,912 positions worth $906B, down 1.5% from $920B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
JP Morgan Chase's Q3 2023 filing shows 1,008 new, 2,453 increased, 3,090 reduced and 491 closed positions. Its largest new stake was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2023 buy was JPMorgan Global Select Equity ETF: 18,266,376 shares worth $849M.
- JP Morgan Chase added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $3.72B increase.
- JP Morgan Chase's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.62B.
- JP Morgan Chase fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $314M.
- JP Morgan Chase's ten largest holdings make up 19% of its $906B portfolio in Q3 2023.
- JP Morgan Chase opened 1,008 new positions and closed 491 in Q3 2023.
- JP Morgan Chase's portfolio value fell 1.5% quarter-over-quarter to $906B.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.